Product
소개
SynaBridge ELISA For Synagis Biosimilar Comparison
Complete kit for the systematic 3-D conformational comparability analysis of
Synagis biosimilar molecule to Palivizumab (Synagis trade name)
Palivizumab is a humanized monoclonal antibody directed against an antigenic site in respiratory syncytial virus (RSV). Palivizumab targets the fusion protein of RSV and thereby inhibits entry into the cell of the virus, preventing infection. It is recommended for infants that are high risk for RSV infection.
This kit will allow for conformational comparison between Synagis Biosimilars and authentic Palivizumab.
주문정보
관련자료